Anterior Chamber Angle Examination in Angle Closure Suspect Patients
1 other identifier
observational
40
1 country
1
Brief Summary
The aim of this study is to detect PACG suspects using both AS OCT and Scheimpflug imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 7, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2022
CompletedJanuary 26, 2022
January 1, 2022
8 months
January 7, 2022
January 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Anterior segment parameters as measured by AS-OCT:
Anterior chamber depth (ACD)..
3 months
Anterior segment parameters as measured by Oculus Pentacam:
Anterior chamber angle (ACA).
3 months
Anterior segment parameters by ASOCT
Angle opening distance at 750 µm (AOD750).
3 months
Anterior segment parameters by OCT
Anterior chamber angle (ACA).
3 months
Pentacam parameters
Anterior chamber volume (ACV).
3 months
Pentacam parameters by Oculus Pentacam:
Anterior chamber depth (ACD).
3 months
Study Arms (1)
40 pateint glucoma suspect
ASOCT
Interventions
Eligibility Criteria
Residents of Minia Governorate diagnosed with SLE with renal affection and without renal affection.
You may qualify if:
- Hyperopes. 2-Shallow AC. 3-With gonioscopy carried out under dim-light conditions without indentation ,with the eye in primary position there is inability to visualize ≤ 180° of the posterior trabecular meshwork (TM) in the absence of peripheral anterior 4-IOP ≤ 21 as measured by tonometry. 5-Normal visual field on static automated perimetry (SAP) testing. 5-Normal optic nerve head (ONH) appearance on fundus biomicroscopy. 6-Family history of primary angle closure disease.
You may not qualify if:
- Eyes with significant corneal opacity that can impare signal strings of any of the used imaging modalities.
- Eyes wih history of intraocular surgery (e.g. cataract surgery ,retinal detachment surgery).
- Eyes with history of laser procedures (e.g.laser peripheral iridotomy). 4-Eyes with anterior segment pathology as iridocyclitis or angle disgenesis 5. Eyes with history of trauma. 6- Eyes with findings suggestive of 2dry cause of glaucoma (e.g. iris or angle neovascularization, any iris or corneal abnormalities, dilated episcleral vessels ).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University hospital
Minya, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Salah
Minia University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 7, 2022
First Posted
January 26, 2022
Study Start
April 1, 2019
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
January 26, 2022
Record last verified: 2022-01